GENMAB

genmab-logo

Genmab is a biotechnology company focused on developing fully human antibody therapeutics for the potential treatment of cancer. Its discovery, development, and manufacturing teams are using cutting-edge technology to create and develop products to address unmet medical needs.
#SimilarOrganizations #People #Financial #Event #Website #More

GENMAB

Social Links:

facebook

Facebook

linkedin

Linkedin

twitter

Twitter

Industry:
Biotechnology Health Care Manufacturing Medical

Founded:
1999-01-01

Address:
Copenhagen, Hovedstaden, Denmark

Country:
Denmark

Website Url:
http://www.genmab.com

Total Employee:
501+

Status:
Active

Contact:
+ 45 7020 2728

Email Addresses:
[email protected]

Total Funding:
204.3 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

cel-sci-logo

CEL-SCI

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

genclis-logo

Genclis

Genclis is a biotechnology company focused on developing therapies for both human and animal health using Transcription Infidelity (“TI”).


Current Advisors List

emil-poulsen_image

Emil Poulsen Associate Director CMC @ Genmab
Board_member
2021-01-01

arnout-gerritsen_image

Arnout Gerritsen Senior Director Bioanalytical Science @ Genmab
Board_member
2021-01-01

Current Employees Featured

jan-van-de-winkel_image

Jan van de Winkel
Jan van de Winkel President & Chief Executive Officer @ Genmab
President & Chief Executive Officer
2010-01-01

martine-van-vugt_image

Martine van Vugt
Martine van Vugt Chief of Staff @ Genmab
Chief of Staff

david-eatwell_image

David Eatwell
David Eatwell CFO & Executive Vice President @ Genmab
CFO & Executive Vice President

anthony-mancini_image

Anthony Mancini
Anthony Mancini EVP & Chief Operating Officer @ Genmab
EVP & Chief Operating Officer
2020-03-01

janine-schuurman_image

Janine Schuurman
Janine Schuurman Senior Vice President, Head Antibody Research & Technology @ Genmab
Senior Vice President, Head Antibody Research & Technology
2021-01-01

judith-klimovsky_image

Judith Klimovsky
Judith Klimovsky Executive Vice President & Chief Development Officer @ Genmab
Executive Vice President & Chief Development Officer
2017-02-01

birgitte-stephensen_image

Birgitte Stephensen
Birgitte Stephensen Senior Vice President, IPR & Legal @ Genmab
Senior Vice President, IPR & Legal

michael-bauer_image

Michael Bauer
Michael Bauer Senior Vice President, Head of Operations R&D @ Genmab
Senior Vice President, Head of Operations R&D
2018-01-01

anthony-pagano_image

Anthony Pagano
Anthony Pagano Chief Financial Officer @ Genmab
Chief Financial Officer
2020-03-01

janine-schuurman_image

Janine Schuurman
Janine Schuurman Corporate Vice President Research & Innovation @ Genmab
Corporate Vice President Research & Innovation
2018-01-01

Founder


don-drakeman_image

Don Drakeman

jan-van-de-winkel_image

Jan van de Winkel

Stock Details


Company's stock symbol is NASDAQ:GMAB

Investors List

glaxosmithkline_image

GlaxoSmithKline

GlaxoSmithKline investment in Post-IPO Equity - Genmab

index-ventures_image

Index Ventures

Index Ventures investment in Venture Round - Genmab

lodh-immunology-fund_image

LODH Immunology Fund

LODH Immunology Fund investment in Venture Round - Genmab

bankinvest-biomedical-venture_image

BankInvest Biomedical Venture

BankInvest Biomedical Venture investment in Venture Round - Genmab

dansk-erhvervsinvestering_image

Dansk Erhvervsinvestering

Dansk Erhvervsinvestering investment in Venture Round - Genmab

apax-partners-france_image

Apax Partners France

Apax Partners France investment in Venture Round - Genmab

bankinvest-biomedical-venture_image

BankInvest Biomedical Venture

BankInvest Biomedical Venture investment in Venture Round - Genmab

dansk-erhvervsinvestering_image

Dansk Erhvervsinvestering

Dansk Erhvervsinvestering investment in Venture Round - Genmab

Investments List

Date Company Article Money raised
2021-06-07 Bolt Biotherapeutics Genmab investment in Post-IPO Equity - Bolt Biotherapeutics 15 M USD

Official Site Inspections

http://www.genmab.com Semrush global rank: 1.66 M Semrush visits lastest month: 14.83 K

  • Host name: 172.66.0.190
  • IP address: 172.66.0.190
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Genmab" on Search Engine

dfkcompany.com © 2022. All rights reserved